ClinicalTrials.Veeva

Menu

Evaluation of Coagulation Factors and Point-of-care Devices During Veno-venous ECMO Therapy

U

University Hospital Goettingen

Status

Completed

Conditions

Extracorporeal Membrane Oxygenation Complication
Coagulation Factor Deficiency

Treatments

Diagnostic Test: Detailed coagulation monitoring

Study type

Observational

Funder types

Other

Identifiers

NCT03754868
19/5/13

Details and patient eligibility

About

Hemorrhagic and thromboembolic complications are common in Veno-venous ECMO therapy. The aim of this study is to provide a detailed analysis of the activity of different coagulation factors and changes in functional coagulation measurements as in rotational thrombelastometry and multiple electrode aggregometry in the course of ECMO therapy.

Enrollment

20 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Need for a Veno-venous extracorporeal membrane oxygenation therapy

Exclusion criteria

  • Known coagulation disorders
  • Refusal to participate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems